Search results
ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly
Zacks via Yahoo Finance· 1 year agoProQR (PRQR) expands its existing licensing and collaboration agreement with Eli Lilly for the...
While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12%...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Significant control over ProQR Therapeutics by individual investors implies that the...
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are retail investors with 50% stake, while 31% is...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights The considerable ownership by retail investors in ProQR Therapeutics indicates that...
ProQR (PRQR) Reports Q2 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoProQR (PRQR) delivered earnings and revenue surprises of 15.38% and 9.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to...
ProQR Therapeutics' (NASDAQ:PRQR) investors will be pleased with their impressive 109% return over...
Simply Wall St. via Yahoo Finance· 11 months agoProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders might understandably be very concerned that the...
Individual investors account for 45% of ProQR Therapeutics N.V.'s (NASDAQ:PRQR) ownership, while...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of ProQR Therapeutics N.V. (NASDAQ:PRQR), it is important...
ProQR Therapeutics N.V. (NASDAQ:PRQR) Could Be Less Than A Year Away From Profitability
Simply Wall St. via Yahoo Finance· 1 year agoWe feel now is a pretty good time to analyse ProQR Therapeutics N.V.'s (NASDAQ:PRQR) business as it...
ProQR Therapeutics (NASDAQ:PRQR) shareholders have endured a 83% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 1 year agoProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders will doubtless be very grateful to see the share...
Investors in ProQR Therapeutics (NASDAQ:PRQR) have unfortunately lost 90% over the last three years
Simply Wall St. via Yahoo Finance· 2 years agoAs an investor, mistakes are inevitable. But really big losses can really drag down an overall...
ProQR Therapeutics Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 2 years agoProQR Therapeutics (NASDAQ:PRQR) Third Quarter 2022 ResultsKey Financial Results Net loss: €24.4m...